Psoriasis: Basic Facts

Size: px
Start display at page:

Download "Psoriasis: Basic Facts"

Transcription

1 Psoriasis Module

2 Module Instructions The following module contains hyperlinked information which serves to offer more information on topics you may or may not be familiar with. We encourage that you read all the hyperlinked information.

3 Psoriasis: Basic Facts Psoriasis is a inflammatory disease of the skin It affects approximately 2% of the U.S. population Age of onset occurs in two peaks: ages and ages ,, but can be seen at any age There is a strong genetic component 1 out of 3 patients with psoriasis has a family member with psoriasis

4 Psoriasis: Basic Facts There are many forms of psoriasis, however this module will focus on PLAQUE PSORIASIS as it is by far the most common form accounting for >90% of cases It is characterized by erythematous, well demarcated plaques with an adherent, silvery scale ( micaceous( scale ) Micaceous refers to the fact that psoriasis scale peels in layers

5 Psoriasis: Pathogenesis The pathogenesis of psoriasis involves the activation of T cells by components of the innate immune system, and release of inflammatory cytokines In contrast to atopic dermatitis which favors a Th2 response, psoriasis favors a Th1/Th17 immune response

6 Typical Psoriatic Plaque On exam, there are three well-demarcated plaques with overlying silvery scale and underlying erythema

7 Case 1

8 Case 1: History HPI: A 24 year-old male walks into your office and shows you a red spot around his belly button that has been present for a month and itches at times. Having been doing reading on the internet he asks: Do I have psoriasis?

9 Case 1: Question 1 What elements in the history are important to ask in this case to arrive at a diagnosis of psoriasis? a. Recent illnesses / Past medical history b. Medications c. Family history d. Social history e. All of the above

10 Case 1: Question 1 Answer: e What elements in the history are important to ask in this case to arrive at a diagnosis? a. Recent illnesses / Past medical history b. Medications c. Family history d. Social history e. All of the above

11 Why ask Recent Illnesses and PMH? Psoriasis can be triggered by infections, especially streptococcal pharyngitis Psoriasis is more severe in patients with HIV Psoriasis is more common in patients with Crohn s disease Psoriasis co-morbidities include depression and the metabolic syndrome It is important to explore how the patient is coping with the illness given the increased risk of depression There is a positive correlation between stress and disease severity Up to 20% of psoriasis patients have psoriatic arthritis, which can lead to joint deformities

12 Why ask about Medications? Psoriasis can be triggered or exacerbated by a number of medications including: Systemic corticosteroid withdrawal Interferons Lithium Beta blockers Antimalarials Gemfibrozil

13 Why ask Family History? There is a strong genetic predisposition to developing psoriasis If a patient has family members with psoriasis, it makes the diagnosis much more likely in that patient 1/3 of psoriasis patients have a positive family history HOWEVER, this means up to 2/3 of patients with psoriasis do not have a family history of psoriasis, so a negative FH does not rule it out!

14 Why ask Social History? Psoriasis can be worsened by alcohol use and smoking Psoriasis can appear in areas of trauma to skin, a phenomenon known as koebnerization Inquire about occupation and recreational hobbies

15 Back to Case 1

16 Case 1: History PMH: none FH: patient is adopted and does not know his family history SH: patient lives with his wife in the city. He denies any history of smoking or drug use. He reports that he does drink beers on weekends. ROS: +pruritus+

17 Case 1: Question 2 You are now ready to examine the patient. In addition to checking the spot lesions the patient mentions, which of the following other place(s) is(are) ) most important to check in evaluating for psoriasis? a. flexor surfaces b. mucous membranes c. gluteal fold d. face e. only the spot lesions the patient mentions

18 Case 1: Question 2 Answer: c You are now ready to examine the patient. In addition to checking the spot lesions the patient mentions, which of the following other place(s) is(are) ) important to check in evaluating this patient for psoriasis? a. flexor surfaces (would be more characteristic of atopic dermatitis) b. mucous membranes (not associated with psoriasis) c. gluteal fold d. face e. only the spot lesions the patient mentions

19 Location is Critical! Although you should perform a full body skin exam, plaque psoriasis tends to appear in CHARACTERISTIC locations which you should ALWAYS check Key Areas: scalp, ears, elbows and knees (extensor surfaces), umbilicus, gluteal cleft, nails, and sites of recent trauma Observation of psoriatic lesions in these locations helps distinguish psoriasis from other papulosquamous disorders

20 Case 1: Exam On exam, Gen: well appearing in NAD Skin: a erythematous plaque with small amounts of fine overlying scale is present around the umbilicus

21 Case 1: Exam After performing a full body skin exam you find an additional lesion Skin: a erythematous plaque with overlying silvery scale is present in the gluteal cleft NOTE: FULL BODY SKIN CHECK in a patient with psoriasis can yield findings that the patient is unaware of. Remember, many patients do not regularly see their buttocks and thus would not know to tell you about it!

22 Case 1: Question 3 What study would most assist you in arriving at a diagnosis? a. KOH prep b. blood test to evaluate for psoriasis antibodies c. Wood s s light examination d. all of the above

23 Case 1: Question 3 Answer: a What study would most assist you in arriving at a diagnosis? a. KOH prep (rule out fungal infection) b. blood test to evaluate for psoriasis antibodies (does not exist) c. Wood s s light examination d. all of the above

24 Case 1: Labs KOH prep does not show the presence of any hyphae and the patient is diagnosed with plaque psoriasis given the presence of psoriatic plaques in typical anatomic areas

25 Psoriasis: Differential Diagnosis Despite psoriasis having a long differential diagnosis, it is typically diagnosed on clinical exam due to its characteristic location and appearance. Listed are other diagnoses that are on the differential: ial: Tinea corporis: : Scaly pink plaque with elevated rim and central clearing; KOH+ Pityriasis rosea: : Herald patch, Christmas tree pattern on trunk Nummular eczema: : Minimal scale, more pruritic Seborrheic dermatitis: : Ill-defined erythema with greasy yellow- brown scale Cutaneous T cell lymphoma: Ill-defined pink patches around buttocks Pityriasis Rubra Pilaris: : Salmon-colored erythema with islands of sparing; waxy palms and soles Others: Secondary syphilis, drug eruption,, sub-acute cutaneous lupus

26 Case 2

27 Case 2: History HPI: 68 yo man with severe psoriasis presents with increased joint pain and deformity. He is currently treating his psoriasis with topical clobetasol. PMH: psoriasis x 40yrs All: none Meds: topical clobetasol FH: mother and father both had psoriasis SH: lives with his wife in the city ROS: negative

28 Case 2: Exam On exam, Gen: well appearing in NAD Skin: Scalp: on the anterior scalp there is a large erythematous plaque with overlying silvery scale Ear: erythematous plaque with overlying silvery scale behind the ear and at the entrance of the canal

29 Case 2: Exam On exam, Extremities: the extensor surface of the left arm has erythematous plaques with overlying silvery scale. Note that the patient also has vitiligo with macular depigmentation in the same region Nails: there is extensive nail pitting and nail dystrophy Nail pitting Nail dystrophy

30 Case 2: Exam On exam, There is notable swelling of the interphalangeal joints

31 Case 2: Question 1 Which of the following is the most likely cause of this patient s interphalangeal joint swelling? a. rheumatoid arthritis b. psoriatic arthritis c. lupus d. gout

32 Case 2: Question 1 Answer: b Which of the following is the most likely cause of this patient s interphalangeal joint swelling? a. rheumatoid arthritis b. psoriatic arthritis c. lupus d. gout

33 Psoriatic Arthritis Psoriatic arthritis is arthritis in the presence of psoriasis Up to 20% of psoriasis patients will develop psoriatic arthritis It is NOT related to the severity of psoriasis 80-90% of psoriatic arthritis cases are accompanied by nail findings of psoriasis

34 Another Example of Psoriatic Arthritis On exam, Patient has erythematous feet bilaterally with desquamation of the overlying skin as well as joint swelling and deformity (arthritis mutilans)

35 Case 3

36 Case 3: History HPI: An 18 year old healthy female with a new diagnosis of psoriasis reports lesions localized to her knees with no other affected areas. She has not tried any therapy. PMH: none All: none Meds: none FH: non-remarkable SH: lives in the city with her parents and attends high school ROS: slight pruritus

37 Case 2: Exam On exam, Gen: well appearing in NAD Skin: erythematous plaques with overlying silvery scale on the extensor surface of the knee.

38 Case 3: Question 1 What is your initial treatment recommendation? a. systemic steroids b. immunomodulators c. high potency topical steroid d. low potency topical steroid e. all of the above

39 Case 3: Question 1 Answer: c What is your initial treatment recommendation? a. systemic steroids b. immunomodulators c. high potency topical steroid d. low potency topical steroid e. all of the above

40 Psoriasis: Treatment Since the psoriasis is localized (less than 3% body surface area), topical treatment is appropriate First line agents: High potency topical steroid in combination with calcipotriene (vitamin D analog Dovonex) Other topical options: tazarotene,, salicylic or lactic acid, tar, calcineurin inhibitors

41 Psoriasis: Topical Treatment Medication Corticosteroids Calcipotriene (Dovonex) Tazarotene (Tazorac) Salicylic acid or Lactic acid Tar Calcineurin inhibitors (Elidel or Protopic) Pros Excellent efficacy No skin atrophy Good second line agent Reduces hyperkeratosis Highly effective Excellent for thin- skinned areas such as eyelids and face Cons Possible skin atrophy Weak when used alone; irritation May burn, sting; Pregnancy category X May burn, sting Messy to use Minimally effective on trunk and extremities

42 Clinical Pearl Topical medications for psoriasis are more effective when used with occlusion which allows for better penetration A bandage, saran-wrap, gloves, or socks placed over the medication can serve this purpose

43 Case 3: Question 2 What would be an appropriate treatment if the patient had presented like this? a. systemic steroid b. topical steroid c. topical steroid and systemic steroid d. topical steroid and UV light therapy e. all of the above

44 Case 3: Question 2 Answer: d What would be an appropriate treatment if the patient had presented like this? a. systemic steroid b. topical steroid c. topical steroid and systemic steroid d. topical steroid and UV light therapy e. all of the above

45 Psoriasis: Treatment Since the psoriasis is generalized (multiple areas and more than 3% body surface area), systemic treatment is required and should be supplemented with topical treatment Many patients with generalized psoriasis are given only topical medications and never get better don don t t make this mistake! ORAL STEROIDS SHOULD NEVER BE USED IN PSORIASIS AS THEY CAN SEVERELY FLARE PSORIASIS UPON DISCONTINUATION!

46 Psoriasis: Systemic Treatment In addition to topical high potency corticosteroids, there are 3 choices for systemic treatment: 1. Phototherapy: narrow-band ultraviolet B light (nbuvb( nbuvb), broad-band band ultraviolet B light (bbuvb( bbuvb), or psoralen plus ultraviolet A light (PUVA) 2. Oral medications: methotrexate, acitretin (Soriatane( Soriatane), cyclosporine (Neoral( Neoral) 3. Biologic Agents: etanercept (Enbrel( Enbrel), adalumimab (Humira), infliximab (Remicade( Remicade), alefacept (Amevive), efaluzimab (Raptiva) The choice of systemic therapy depends on 3 factors: convenience, side effect risk profile, and presence or absence of psoriatic arthritis (PsA( PsA)

47 Psoriasis Systemic Therapy Treatment Pros Cons Helps PsA? Phototherapy Very Safe; OK in pregnancy (except PUVA) Time consuming (3x week) No Methotrexate Inexpensive; weekly dosing convenient Possible hematologic and liver toxicity; GI upset; Pregnancy X Yes Acitretin (Soriatane) Synergistic with phototherapy Possible elevation of lipids, LFTs; ; Pregnancy X No Cyclosporine (Neoral) Highly effective Renal toxicity, HTN, increased malignancy No TNF Biologics (Enbrel, Humira, Remicade) No organ toxicity and medication interactions Expensive; increased risk of infections and possibly malignancy Yes Other Biologics (Amevive, Raptiva) No organ toxicity and medication interactions Expensive; not as effective as TNF agents No

48 Other Types of Psoriasis Besides plaque psoriasis, there are several other psoriasis sub-types to be aware of: Guttate Inverse Pustular Hand and Foot (Palmoplantar) Erythrodermic

49 Guttate Psoriasis Acute onset of raindrop-sized lesions on trunk and extremities in young adults, often preceded by streptococcal pharyngitis

50 Inverse Psoriasis Erythematous plaques in the axilla,, groin, inframammary region, and other flexural areas. May lack scale due to moistness of area.

51 Pustular Psoriasis Characterized by psoriatic lesions with sterile pus. May result from corticosteroid withdrawal. When generalized, pustular psoriasis can be a life- threatening emergency due to the risk of sepsis. These patients should be hospitalized and a dermatologist consulted.

52 Hand and Foot Psoriasis May occur as either plaque type or pustular type. Often very functionally disabling for the patient. Treatment is often with topicals plus occlusion, or PUVA. Plaque type palmoplantar psoriasis Pustular type palmoplantar psoriasis

53 Erythrodermic Psoriasis Involves almost the entire skin surface; skin is bright red. Associated with fever, chills, and malaise. Like pustular psoriasis, sis, hospitalization is sometimes required.

54 END OF MODULE

Psoriasis. Psoriasis. Mark A. Bechtel, M.D. Director of Dermatology The Ohio State University College of Medicine

Psoriasis. Psoriasis. Mark A. Bechtel, M.D. Director of Dermatology The Ohio State University College of Medicine Psoriasis Mark A. Bechtel, M.D. Director of Dermatology The Ohio State University College of Medicine Psoriasis Psoriasis is a chronic skin disorder resulting from a polygenic predisposition combined with

More information

X-Plain Psoriasis Reference Summary

X-Plain Psoriasis Reference Summary X-Plain Psoriasis Reference Summary Introduction Psoriasis is a long-lasting skin disease that causes the skin to become inflamed. Patches of thick, red skin are covered with silvery scales. It affects

More information

FastTest. You ve read the book... ... now test yourself

FastTest. You ve read the book... ... now test yourself FastTest You ve read the book...... now test yourself To ensure you have learned the key points that will improve your patient care, read the authors questions below. Please refer back to relevant sections

More information

PATIENT RESOURCES: PSORIASIS

PATIENT RESOURCES: PSORIASIS PATIENT RESOURCES: PSORIASIS Psoriasis is a persistent skin disorder in which there are red, thickened areas with silvery scales, most often on the scalp, elbows, knees, and lower back. Some cases, of

More information

Psoriasis Treatment Transition Pathway

Psoriasis Treatment Transition Pathway Psoriasis Treatment Transition Pathway A Treatment Support Tool Adapted from Circle Nottingham NHS Treatment Centre Psoriasis Pathway (under consultation) with support from Abbvie Ltd Treatment Pathways

More information

Is Monotherapy Treatment of Etanercept Effective Against Plaque Psoriasis?

Is Monotherapy Treatment of Etanercept Effective Against Plaque Psoriasis? Philadelphia College of Osteopathic Medicine DigitalCommons@PCOM PCOM Physician Assistant Studies Student Scholarship Student Dissertations, Theses and Papers 2011 Is Monotherapy Treatment of Etanercept

More information

GENETIC ANALYSIS OF PSORIASIS AND PSORIATIC ARTHRITIS Department of Dermatology, University of Michigan

GENETIC ANALYSIS OF PSORIASIS AND PSORIATIC ARTHRITIS Department of Dermatology, University of Michigan GENETIC ANALYSIS OF PSORIASIS AND PSORIATIC ARTHRITIS Department of Dermatology, University of Michigan SELF ASSESSMENT FORM FOR STUDY SUBJECTS AND CONTROLS Accession Number (will be filled in by lab)

More information

Hitchcock Clinic Manchester, NH. Psoriasis. Overview. Psoriasis 3/9/2009. From heartbreak to heart attack. Mark Quitadamo, MD

Hitchcock Clinic Manchester, NH. Psoriasis. Overview. Psoriasis 3/9/2009. From heartbreak to heart attack. Mark Quitadamo, MD Hitchcock Clinic Manchester, NH Psoriasis From heartbreak to heart attack Mark Quitadamo, MD Overview Psoriasis and psoriatic arthritis are common skin and joint disease Psoriasis Unfortunately it is a

More information

Public Forum on Psoriasis. 2011 National Series

Public Forum on Psoriasis. 2011 National Series Public Forum on Psoriasis 2011 National Series Jerry Tan MD FRCPC Schulich School of Medicine and Dentistry, University of Western Ontario Windsor, Ontario, Canada Presented at Caboto Club, Windsor, April

More information

PSORIASIS. -Multi factorial. -Papulosquamous disorder. -Genetically determined (few) -Chronic Scaly lesions. -Seasonal variations

PSORIASIS. -Multi factorial. -Papulosquamous disorder. -Genetically determined (few) -Chronic Scaly lesions. -Seasonal variations PSORIASIS -Multi factorial -Papulosquamous disorder -Genetically determined (few) -Chronic Scaly lesions -Seasonal variations -Recurrences & remissions Etiology & Pathogenesis T-cell mediated autoimmune

More information

For more information, please contact the National Psoriasis Foundation at 800-723-9166 or

For more information, please contact the National Psoriasis Foundation at 800-723-9166 or For more information, please contact the National Psoriasis Foundation at 800-723-9166 or www.psoriasis.org. PSORIASIS 101: LEARNING TO LIVE IN THE SKIN YOU RE IN is part of an awareness program to educate

More information

A Psoriasis. Clinical Presentation. 2 Types of Psoriasis. Plaque Psoriasis. 1 Introduction

A Psoriasis. Clinical Presentation. 2 Types of Psoriasis. Plaque Psoriasis. 1 Introduction Clinical Presentation A Psoriasis Jennifer Soung, Mark Lebwohl Contents 1 Introduction 67 2 Types of Psoriasis 67 Plaque Psoriasis 67 Guttate Psoriasis 68 Pustular Psoriasis 69 Inverse Psoriasis 70 Erythrodermic

More information

Psoriasis. Student's Name. Institution. Date of Submission

Psoriasis. Student's Name. Institution. Date of Submission Running head: PSORIASIS Psoriasis Student's Name Institution Date of Submission PSORIASIS 1 Abstract Psoriasis is a non-contagious chronic skin disease that is characterized by inflammatory and multiplying

More information

Psoriasis Can be Cured with Homoeopathy

Psoriasis Can be Cured with Homoeopathy Homoeopathy Clinic http://www.homoeopathyclinic.com Psoriasis Can be Cured with Homoeopathy Case Report / General Information What you should Know about Psoriasis? It is not a contagious disease. Psoriasis

More information

Psoriasis and lichen planus. Department of Dermatology SRM MCH & RC

Psoriasis and lichen planus. Department of Dermatology SRM MCH & RC Psoriasis and lichen planus Department of Dermatology SRM MCH & RC WHAT IS PSORIASIS Psoriasis is a common, chronic, disfiguring, inflammatory and proliferative condition of the skin; in which both genetic

More information

An Overview of Psoriasis: The Etiology, Common Triggers, and Current Treatment Options

An Overview of Psoriasis: The Etiology, Common Triggers, and Current Treatment Options An Overview of Psoriasis: The Etiology, Common Triggers, and Current Treatment Options Release Date: 01/17/2012 Expiration Date: 01/17/2013 FACULTY: Kathryn Haldiman MS, RN FACULTY AND ACCREDITOR DISCLOSURE

More information

PSORIATIC ARTHRITIS. Chryssanthie Kafkala, M.D. INTRODUCTION:

PSORIATIC ARTHRITIS. Chryssanthie Kafkala, M.D. INTRODUCTION: PSORIATIC ARTHRITIS Chryssanthie Kafkala, M.D. INTRODUCTION: Psoriatic arthritis is a disease with generally good prognosis. Both ocular and systemic involvement is usually benign, however, the following

More information

Leukocytoclastic Vasculitis and Stasis Dermatitis With Id Reaction

Leukocytoclastic Vasculitis and Stasis Dermatitis With Id Reaction Id Reaction December 01, 2007 By David L. Kaplan, MD [1] A Photo Quiz to Hone Dermatologic Skills Case 1: A slightly pruritic eruption developed on the lower legs of a 39-year-old woman after she had an

More information

2-5 % Europeans A distressing, life-long, inflammatory disease Impairs patients Quality of Life

2-5 % Europeans A distressing, life-long, inflammatory disease Impairs patients Quality of Life Psoriasis: 2-5 % Europeans A distressing, life-long, inflammatory disease Impairs patients Quality of Life 15-25%: moderate-to-severe disease - candidates for systemic therapies - often difficult to manage

More information

Highlights on Clinical Picture of Psoriasis

Highlights on Clinical Picture of Psoriasis Highlights on Clinical Picture of Psoriasis PROF DR DOAA MAHGOUB CAIRO UNIVERSITY 1 Chronic Plaque Psoriasis Symmetric distribution of sharply defined, erythematous, scaly plaques. The scalp, elbows, knees

More information

Psoriasis - suspected

Psoriasis - suspected Psoriasis - suspected Possible link to alcohol use, depression, other medications History and examination Consider referral to Health Trainers Consider differential diagnoses Is the patient systemically

More information

An overview of. PSORIASIS and PSORIATIC ARTHRITIS.» Diagnosis» Symptoms» Triggers» Treatments

An overview of. PSORIASIS and PSORIATIC ARTHRITIS.» Diagnosis» Symptoms» Triggers» Treatments An overview of PSORIASIS and PSORIATIC ARTHRITIS» Diagnosis» Symptoms» Triggers» Treatments WHAT IS PSORIASIS? PSORIASIS is pronounced sore-eye-ah-sis. It is an autoimmune disease, meaning that certain

More information

What is Psoriasis? Common Areas Affected. Type Who Does it Affect Characteristics

What is Psoriasis? Common Areas Affected. Type Who Does it Affect Characteristics What is? is a term derived from the Greek word psōra which means itch and is a common, long lasting, inflammatory skin condition which affects 1-3% of the UK population and about 80 million people worldwide.

More information

Psoriasis: an overview

Psoriasis: an overview 22 September/October 2012 SOUTH AFRICAN RHEUMATOLOGY JOURNAL ARTICLE Psoriasis: an overview Dr WH Fouche Dermatologist in private practice George Introduction The term psoriasis refers to a chronic inflammatory

More information

Phenotypes and Classification of Psoriasis

Phenotypes and Classification of Psoriasis Rheumatology 2010 Birmingham 21 April 2010 Phenotypes and Classification of Psoriasis Christopher E.M. Griffiths Abbott Centocor Incyte Galderma Janssen-Cilag Leo Pharma Lynxx Novartis Pfizer Schering-Plough

More information

Biologic Treatments for Rheumatoid Arthritis

Biologic Treatments for Rheumatoid Arthritis Biologic Treatments Rheumatoid Arthritis (also known as cytokine inhibitors, TNF inhibitors, IL 1 inhibitor, or Biologic Response Modifiers) Description Biologics are new class of drugs that have been

More information

Treating Psoriasis Naturally. Dr. Deborah Ardolf, ND

Treating Psoriasis Naturally. Dr. Deborah Ardolf, ND Treating Psoriasis Naturally by Dr. Deborah Ardolf, ND Psoriasis is an extremely common, noncontagious skin disorder affecting between 2% to 4% of the United States population. Psoriasis affects men and

More information

PSORIASIS AND ITS. Learn how vitamin D medications play an important role in managing plaque psoriasis

PSORIASIS AND ITS. Learn how vitamin D medications play an important role in managing plaque psoriasis PLAQUE PSORIASIS AND ITS TREATMENTS Learn how vitamin D medications play an important role in managing plaque psoriasis 2 Understanding Plaque Psoriasis WHAT CAUSES PLAQUE PSORIASIS? No one knows exactly

More information

Topical Tacrolimus or Pimecrolimus for the treatment of mild, moderate or severe atopic eczema. Effective Shared Care Agreement

Topical Tacrolimus or Pimecrolimus for the treatment of mild, moderate or severe atopic eczema. Effective Shared Care Agreement Topical Tacrolimus or Pimecrolimus for the treatment of mild, moderate or severe atopic eczema. Effective Shared Care Agreement A Copy of this page signed by all three parties should be retained in the

More information

CLINICAL PRESENTATION OF PSORIASIS

CLINICAL PRESENTATION OF PSORIASIS CLINICAL PRESENTATION OF PSORIASIS F. AYALA Division of Dermatology, Department of Systematic Pathology, University of Naples Federico II, Naples, Italy SUMMARY Psoriasis is a chronic, inflammatory disease

More information

Rheumatoid Arthritis

Rheumatoid Arthritis Rheumatoid Arthritis While rheumatoid arthritis (RA) has long been feared as one of the most disabling types of arthritis, the outlook has dramatically improved for many newly diagnosed patients. Certainly

More information

Drug Therapy Guidelines: Humira (adalimumab)

Drug Therapy Guidelines: Humira (adalimumab) Drug Therapy Guidelines: Humira (adalimumab) Effective Date: 5/1/08 Committee Review Date: 1/6/01, 9/18/01, 1/15/02, 1/7/03, 1/20/04, 1/18/05, 12/7/05, 10/15/06, 7/2/07, 11/5/07, 3/25/08 Policy Statements:

More information

Arthritis and Rheumatology Clinics of Kansas Patient Education. Reactive Arthritis (ReA) / Inflammatory Bowel Disease (IBD) Arthritis

Arthritis and Rheumatology Clinics of Kansas Patient Education. Reactive Arthritis (ReA) / Inflammatory Bowel Disease (IBD) Arthritis Arthritis and Rheumatology Clinics of Kansas Patient Education Reactive Arthritis (ReA) / Inflammatory Bowel Disease (IBD) Arthritis Introduction: For as long as scientists have studied rheumatic disease,

More information

Psoriatic arthritis FACTSHEET

Psoriatic arthritis FACTSHEET 1 What is psoriatic arthritis? Psoriatic arthritis (PsA) is a disease where joints around the body become inflamed and sore. It can make moving about difficult and painful. People who have PsA also have

More information

Psoriatic Arthritis www.arthritis.org.nz

Psoriatic Arthritis www.arthritis.org.nz Psoriatic Arthritis www.arthritis.org.nz Did you know? Arthritis affects one in six New Zealanders over the age of 15 years. Psoriatic arthritis usually appears in people between the ages of 30 to 50.

More information

Childhood Psoriasis a challenge to all

Childhood Psoriasis a challenge to all Childhood Psoriasis a challenge to all Jayakar Thomas 1 & Parimalam Kumar 2 1 Senior Consultant Dermatologist, Apollo Children s Hospital, Chennai. India 2 Parimalam Kumar Senior Assistant Professor of

More information

Psoriasis is a chronic inflammatory disease that. A Red, Scaly Rash: How to Recognize and Treat Psoriasis. Psoriasis

Psoriasis is a chronic inflammatory disease that. A Red, Scaly Rash: How to Recognize and Treat Psoriasis. Psoriasis Psoriasis A Red, Scaly Rash: How to Recognize and Treat Psoriasis Case Study and Commentary, Sabrina L. Martin, BA, Tushar S. Dabade, MD, and Steven R. Feldman, MD, PhD Abstract Objective: To review the

More information

Rheumatic Diseases, Psoriasis, and Crohn s Disease

Rheumatic Diseases, Psoriasis, and Crohn s Disease Rheumatic Diseases, Psoriasis, and Crohn s Disease What does this handout cover? This handout has information about rheumatic disease, psoriasis, and Crohn s disease. It also has information on how these

More information

Treating psoriasis and psoriatic arthritis. A booklet for patients and carers

Treating psoriasis and psoriatic arthritis. A booklet for patients and carers Treating psoriasis and psoriatic arthritis A booklet for patients and carers Picture credits Cover Stuart Neville Page 4 Dr P. Marazzi/Science Photo Library CNRI/Science Photo Library CID, ISM/Science

More information

Your psoriasis story. Print this out, answer the questions, then share it with your doctor

Your psoriasis story. Print this out, answer the questions, then share it with your doctor Your psoriasis story Print this out, answer the questions, then share it with your doctor 1 SYMPTOMS Surface Area Your doctor will use a variety of different factors to measure the severity of your disease,

More information

Synopsis of Causation

Synopsis of Causation Ministry of Defence Synopsis of Causation Psoriasis Author: Dr Tony Fisher, Medical Author, Medical Text, Edinburgh Validator: Dr Cameron Kennedy, Bristol Royal Infirmary, Bristol September 2008 Disclaimer

More information

Medicines for Psoriatic Arthritis. A Review of the Research for Adults

Medicines for Psoriatic Arthritis. A Review of the Research for Adults Medicines for Psoriatic Arthritis A Review of the Research for Adults Is This Information Right for Me? Yes, this information is right for you if: Your doctor* has told you that you have psoriatic (pronounced

More information

Guidelines of care for the management of psoriasis and psoriatic arthritis

Guidelines of care for the management of psoriasis and psoriatic arthritis FROM THE ACADEMY Guidelines of care for the management of psoriasis and psoriatic arthritis Section 6. Guidelines of care for the treatment of psoriasis and psoriatic arthritis: Case-based presentations

More information

the psoriasis and psoriatic arthritis pocket guide

the psoriasis and psoriatic arthritis pocket guide the psoriasis and psoriatic arthritis pocket guide Treatment algorithms and management options www.psoriasis.org Authored by: Abby Van Voorhees, M.D. Steven R. Feldman, M.D., Ph.D. John Y. M. Koo, M.D.

More information

Psoriatic Arthritis. having psoriatic arthritis.

Psoriatic Arthritis. having psoriatic arthritis. Psoriatic Arthritis having psoriatic arthritis. Psoriatic arthritis is a chronic disease characterized by a form of inflammation of the skin (psoriasis) and joints (inflammatory arthritis). Psoriasis is

More information

Case Scenarios. Case Scenario 1 Group A

Case Scenarios. Case Scenario 1 Group A Case Scenarios Prior to the workshop please work through the following scenario and be prepared to present this to the rest of the group. You can work in groups of 3-4. Specialist nurses, phototherapy

More information

MEDICAL ASSISTANCE HANDBOOK PRIOR AUTHORIZATION OF PHARMACEUTICAL SERVICES `I. Requirements for Prior Authorization of Cytokine and CAM Antagonists

MEDICAL ASSISTANCE HANDBOOK PRIOR AUTHORIZATION OF PHARMACEUTICAL SERVICES `I. Requirements for Prior Authorization of Cytokine and CAM Antagonists MEDICAL ASSISTANCE HBOOK `I. Requirements for Prior Authorization of Cytokine and CAM Antagonists A. Prescriptions That Require Prior Authorization All prescriptions for Cytokine and CAM Antagonists must

More information

Case 1: Exam. How would you describe these skin findings?

Case 1: Exam. How would you describe these skin findings? The Red Leg Module Instructions The following module contains hyperlinked information which serves to offer more information on topics you may or may not be familiar with. We encourage that you read all

More information

Guidelines of care for the management of psoriasis and psoriatic arthritis

Guidelines of care for the management of psoriasis and psoriatic arthritis FROM THE ACADEMY Guidelines of care for the management of psoriasis and psoriatic arthritis Section 6. Guidelines of care for the treatment of psoriasis and psoriatic arthritis: Case-based presentations

More information

Common Skin Conditions in Children. Liz Moore and Emma King Dermatology Nurse Consultants

Common Skin Conditions in Children. Liz Moore and Emma King Dermatology Nurse Consultants Common Skin Conditions in Children Liz Moore and Emma King Dermatology Nurse Consultants Diagnosis? Nummular Dermatitis Disc pattern rash (discoid eczema) Clearly demarcated edges Occurs at any age Can

More information

National Medicines Information Centre ST. JAMES S HOSPITAL DUBLIN 8 TEL 01-4730589 or 1850-727-727 FAX 01-4730596 E-Mail: nmic@stjames.

National Medicines Information Centre ST. JAMES S HOSPITAL DUBLIN 8 TEL 01-4730589 or 1850-727-727 FAX 01-4730596 E-Mail: nmic@stjames. VOLUME 6 NUMBER 6 2000 PSORIASIS National Medicines Information Centre ST. JAMES S HOSPITAL DUBLIN 8 TEL 01-4730589 or 1850-727-727 FAX 01-4730596 E-Mail: nmic@stjames.ie SUMMARY The aim of treatment is

More information

Psoriasis is a skin condition that causes scaly red patches on your skin. There's no cure for psoriasis, but there are treatments that can help.

Psoriasis is a skin condition that causes scaly red patches on your skin. There's no cure for psoriasis, but there are treatments that can help. Patient information from the BMJ Group Psoriasis What is it? What are the symptoms? How is it diagnosed? How common is it? What treatments work? What will happen? Questions to ask Psoriasis If you get

More information

INDEX Note: PsA stands for psoriatic arthritis. Page numbers in italics indicate figures. Page numbers followed by a t indicate tables. Clinical trials and studies are indexed under the acronym of the

More information

NATIONAL PSORIASIS FOUNDATION SYSTEMIC MEDICATIONS. for psoriasis and psoriatic arthritis including biologics and new oral treatments

NATIONAL PSORIASIS FOUNDATION SYSTEMIC MEDICATIONS. for psoriasis and psoriatic arthritis including biologics and new oral treatments NATIONAL PSORIASIS FOUNDATION SYSTEMIC MEDICATIONS for psoriasis and psoriatic arthritis including biologics and new oral treatments Introduction to psoriasis and psoriatic arthritis WHAT IS PSORIASIS?

More information

Course: Acupuncture Treatment of Disease 3 Date: June 22, 2009 Class #: 10 Psoriasis, Fibromyalgia/CFS. Psoriasis

Course: Acupuncture Treatment of Disease 3 Date: June 22, 2009 Class #: 10 Psoriasis, Fibromyalgia/CFS. Psoriasis Course: Acupuncture Treatment of Disease 3 Date: June 22, 2009 Class #: 10 Psoriasis, Fibromyalgia/CFS (bai bi which translates to skin diseases) Fibromyalgia/CFS Psoriasis 2.02 % of the US population

More information

Disclosures. Consultant and Speaker for Biogen Idec, TEVA Neuroscience, EMD Serrono, Mallinckrodt, Novartis, Genzyme, Accorda Therapeutics

Disclosures. Consultant and Speaker for Biogen Idec, TEVA Neuroscience, EMD Serrono, Mallinckrodt, Novartis, Genzyme, Accorda Therapeutics Mitzi Joi Williams, MD Neurologist MS Center of Atlanta, Atlanta, GA Disclosures Consultant and Speaker for Biogen Idec, TEVA Neuroscience, EMD Serrono, Mallinckrodt, Novartis, Genzyme, Accorda Therapeutics

More information

PRACTICAL HELP FROM THE ARTHRITIS FOUNDATION. www.arthritis.org 800-283-7800. Psoriatic Arthritis

PRACTICAL HELP FROM THE ARTHRITIS FOUNDATION. www.arthritis.org 800-283-7800. Psoriatic Arthritis Psoriatic Arthritis WHAT IS PSORIATIC ARTHRITIS? Psoriatic (sore-ee-aah-tick) arthritis is a condition that causes pain and swelling in joints and scaly patches on the skin. Psoriatic arthritis occurs

More information

TOPICAL TREATMENTS FOR PSORIASIS

TOPICAL TREATMENTS FOR PSORIASIS TOPICAL TREATMENTS FOR PSORIASIS What are the aims of this leaflet? Patients with psoriasis are usually treated with preparations that are applied to the skin. This leaflet has been written to help you

More information

TOPICAL TREATMENTS. for psoriasis NATIONAL PSORIASIS FOUNDATION. » Over-the-counter products» Combination agents» + more

TOPICAL TREATMENTS. for psoriasis NATIONAL PSORIASIS FOUNDATION. » Over-the-counter products» Combination agents» + more NATIONAL PSORIASIS FOUNDATION TOPICAL TREATMENTS for psoriasis» Topical steroids» Vitamin D derivatives» Vitamin A derivatives» Over-the-counter products» Combination agents» + more Photo illustration

More information

TREATMENTS FOR MODERATE OR SEVERE PSORIASIS

TREATMENTS FOR MODERATE OR SEVERE PSORIASIS TREATMENTS FOR MODERATE OR SEVERE PSORIASIS What are the aims of this leaflet? Patients with psoriasis are usually treated with creams and ointments, which are applied to the skin. These are discussed

More information

Psoriasis Field Tests

Psoriasis Field Tests Psoriasis Field Tests Human Test Results Phillips Company www.phillipscompany.4t.com For more information, please see http://psoriasisplus.yolasite.com Page 1 Contents Foreward... 2 A discovery -- Dermoneen

More information

Treatment options a simple guide

Treatment options a simple guide Guide Treatment options a simple guide To decide which treatment is right for you, a good starting point is to know what options you have and to understand the pros and cons of each one. People respond

More information

Psoriasis. Medical Bulletin. Introduction. Clinical Features. Pathology and Pathogenesis. Dr. King-man HO

Psoriasis. Medical Bulletin. Introduction. Clinical Features. Pathology and Pathogenesis. Dr. King-man HO Dr. King-man HO MBBS (HK), MRCP (UK), FHKCP, FHKAM (Medicine), FRCP (Glasgow, Edin), Dip Derm (London), Dip GUM (LAS) Consultant Dermatologist, Social Hygiene Service, CHP Specialist in Dermatology and

More information

Medication Guide Enbrel (en-brel) (etanercept)

Medication Guide Enbrel (en-brel) (etanercept) Medication Guide Enbrel (en-brel) (etanercept) Read the Medication Guide that comes with Enbrel before you start using it and each time you get a refill. There may be new information. This Medication Guide

More information

Understanding Rheumatoid Arthritis

Understanding Rheumatoid Arthritis Understanding Rheumatoid Arthritis Understanding Rheumatoid Arthritis What Is Rheumatoid Arthritis? 1,2 Rheumatoid arthritis (RA) is a chronic autoimmune disease. It causes joints to swell and can result

More information

COMMITTEE FOR MEDICINAL PRODUCTS FOR HUMAN USE (CHMP)

COMMITTEE FOR MEDICINAL PRODUCTS FOR HUMAN USE (CHMP) European Medicines Agency Evaluation of Medicines for Human Use London, 18 November 2004 CHMP/EWP/2454/02 corr COMMITTEE FOR MEDICINAL PRODUCTS FOR HUMAN USE (CHMP) GUIDELINE ON CLINICAL INVESTIGATION

More information

Drug Treatments in Psoriasis

Drug Treatments in Psoriasis Drug Treatments in Psoriasis Authors: David Gravette, Pharm.D. Candidate, Harrison School of Pharmacy, Auburn University; Morgan Luger, Pharm.D. Candidate, Harrison School of Pharmacy, Auburn University;

More information

Before I go into detailed development process, let me draw the attention to this fact that

Before I go into detailed development process, let me draw the attention to this fact that Before I go into detailed development process, let me draw the attention to this fact that Unlike psoriasis heredity plays a big role in Psoriatic Arthritis. Children of parents with psoriatic Up to 40%

More information

EBMT Education Day for Nurses and AHPs April 2012 Skin care: not every rash is GVHD

EBMT Education Day for Nurses and AHPs April 2012 Skin care: not every rash is GVHD EBMT Education Day for Nurses and AHPs April 2012 Skin care: not every rash is GVHD Eileen Parry Consultant Dermatologist Tameside Hospital Foundation Trust Overview How to assess a patient with a rash

More information

VITILIGO Charles Camisa, MD 1/24/12. Vitiligo is a common autoimmune skin disease that causes gradual loss of the natural

VITILIGO Charles Camisa, MD 1/24/12. Vitiligo is a common autoimmune skin disease that causes gradual loss of the natural VITILIGO Charles Camisa, MD 1/24/12 What is vitiligo? Vitiligo is a common autoimmune skin disease that causes gradual loss of the natural brown pigment in the skin called melanin. It affects about 1%

More information

A patient guide to psoriasis/ psoriatic arthritis URAC. All Walgreens specialty pharmacy locations are ACHC and URAC accredited.

A patient guide to psoriasis/ psoriatic arthritis URAC. All Walgreens specialty pharmacy locations are ACHC and URAC accredited. A patient guide to psoriasis/ psoriatic arthritis URAC All Walgreens specialty pharmacy locations are ACHC and URAC accredited. Table of contents Understanding psoriasis and psoriatic arthritis...1 Psoriasis...1

More information

Top 10 Psoriasis Treatment Tips

Top 10 Psoriasis Treatment Tips Top 10 Psoriasis Treatment Tips Steven R. Feldman, MD, PhD Professor of Dermatology, Pathology & Social Sciences Director, Psoriasis Treatment Center Wake Forest University School of Medicine Winston-Salem,

More information

Efficacy and Safety of Calcipotriol Ointment in Psoriasis Vulgaris - Experiences in Hong Kong

Efficacy and Safety of Calcipotriol Ointment in Psoriasis Vulgaris - Experiences in Hong Kong ORIGINAL ARTICLES Efficacy and Safety of Calcipotriol Ointment in Psoriasis Vulgaris - Experiences in Hong Kong Drs. C. W. Fung, L.Y. Chong, C.Y. Leung, C. N. Look, K.K. Lo, K. M. Ho Social Hygiene Service

More information

Once the immune system is triggered, cells migrate from the blood into the joints and produce substances that cause inflammation.

Once the immune system is triggered, cells migrate from the blood into the joints and produce substances that cause inflammation. HealthExchange Points For Your Joints An Arthritis Talk Howard Epstein, MD Orthopaedic & Rheumatologic Institute Rheumatic & Immunologic Disease Cleveland Clinic Beachwood Family Health & Surgery Center

More information

Rheumatoid Arthritis

Rheumatoid Arthritis What is Rheumatoid Arthritis? Rheumatoid Arthritis (RA) is a chronic and systemic disease that causes pain, stiffness, swelling, and limitation in the motion and function of multiple joints. Though joints

More information

How To Choose A Biologic Drug

How To Choose A Biologic Drug North Carolina Rheumatology Association Position Statements I. Biologic Agents A. Appropriate delivery, handling, storage and administration of biologic agents B. Indications for biologic agents II. III.

More information

NURS 821 Alterations in the Musculoskeletal System. Rheumatoid Arthritis. Type III Hypersensitivity Response

NURS 821 Alterations in the Musculoskeletal System. Rheumatoid Arthritis. Type III Hypersensitivity Response NURS 821 Alterations in the Musculoskeletal System Margaret H. Birney PhD, RN Lecture 12 Part 2 Joint Disorders (cont d) Rheumatoid Arthritis Definition: Autoimmune disorder occurring in genetically sensitive

More information

Psoriatic Arthritis Current Guidelines. Linda Sekhon, DHSc, PA-C

Psoriatic Arthritis Current Guidelines. Linda Sekhon, DHSc, PA-C Psoriatic Arthritis Current Guidelines Linda Sekhon, DHSc, PA-C Learning Objectives At the conclusion of this lecture, participants should be able to: Define Psoriatic Arthritis and briefly describe the

More information

Psoriasis. Etiology. Clinical feature. Head to Toe Psoriasis, How to Treat? Precipitating factor 11/19/2012

Psoriasis. Etiology. Clinical feature. Head to Toe Psoriasis, How to Treat? Precipitating factor 11/19/2012 Psoriasis Head to Toe Psoriasis, How to Treat? Charoen Choonhakarn, MD Division of Dermatology, Faculty of Medicine Khon Kaen University Chronic inflammatory skin disease, 1-2% of population Male = female,

More information

GP Symposium Dermatology Dr Seow Hoong Foo Dr Shireen Velangi March 6th 2014

GP Symposium Dermatology Dr Seow Hoong Foo Dr Shireen Velangi March 6th 2014 Psoriasis : It s not just skin de eep NICE Guidelines and Quality Standards: a collaboration to deliver quality care GP Symposium Dermatology y p gy Dr Seow Hoong Foo Dr Shireen Velangi March 6th 2014

More information

Cutaneous Lymphoma FAST FACTS

Cutaneous Lymphoma FAST FACTS Cutaneous Lymphoma FAST FACTS What is Cutaneous Lymphoma? Cutaneous lymphomas are types of non-hodgkin s lymphomas (NHL) that originate in the lymphocytes (white blood cells). Unlike most other types of

More information

biologics for the treatment of psoriasis

biologics for the treatment of psoriasis How to contact us The Psoriasis Association Dick Coles House 2 Queensbridge Northampton NN4 7BF tel: 08456 760 076 (01604) 251 620 fax: (01604) 251 621 email: mail@psoriasis-association.org.uk www.psoriasis-association.org.uk

More information

subcutaneous initially every 4 weeks then every 12 weeks Coverage Criteria: Express Scripts, Inc. monograph dated 02/24/2010

subcutaneous initially every 4 weeks then every 12 weeks Coverage Criteria: Express Scripts, Inc. monograph dated 02/24/2010 BENEFIT DESCRIPTION AND LIMITATIONS OF COVERAGE ITEM: PRODUCT LINES: COVERED UNDER: DESCRIPTION: CPT/HCPCS Code: Company Supplying: Setting: Humira (adalimumab subcutaneous injection) Commercial HMO/PPO/CDHP

More information

Welcome to the December 2011 newsletter from Pure Bio Ltd.

Welcome to the December 2011 newsletter from Pure Bio Ltd. Your Monthly Update Dear Colleague Welcome to the December 2011 newsletter from Pure Bio Ltd. Did you know: Latest research from Tufts Medical Centre, Boston MA has shown that high dietary intake of vitamin

More information

Treatments for severe psoriasis

Treatments for severe psoriasis Treatments for severe psoriasis John R Sullivan, Dermatologist and Clinical Pharmacologist, Southderm Kogarah, Skin and Cancer Foundation Australia, St Vincent s Hospital, and University of New South Wales,

More information

Psoriasis. Background

Psoriasis. Background Psoriasis Plaque psoriasis is a chronic inflammatory disease with an unknown cause and no cure. Much research is based on the theory that psoriasis is a T cell mediated disorder. This review suggests that

More information

Objectives: Immunity Gone Wrong: Autoimmune Diseases in Dental Hygiene Practice

Objectives: Immunity Gone Wrong: Autoimmune Diseases in Dental Hygiene Practice Objectives: 1) Understand the concept of self- tolerance versus non- self- tolerance. 2) Recognize systemic and oral indicators of autoimmune diseases. 3) Identify various autoimmune diseases and their

More information

Immune modulation in rheumatology. Geoff McColl University of Melbourne/Australian Rheumatology Association

Immune modulation in rheumatology. Geoff McColl University of Melbourne/Australian Rheumatology Association Immune modulation in rheumatology Geoff McColl University of Melbourne/Australian Rheumatology Association A traditional start to a presentation on biological agents in rheumatic disease is Plasma cell

More information

MEDICATION GUIDE. PROTOPIC [pro-top-ik] (tacrolimus) Ointment 0.03% Ointment 0.1%

MEDICATION GUIDE. PROTOPIC [pro-top-ik] (tacrolimus) Ointment 0.03% Ointment 0.1% MEDICATION GUIDE PROTOPIC [pro-top-ik] (tacrolimus) Ointment 0.03% Ointment 0.1% Read the Medication Guide every time you or a family member gets PROTOPIC Ointment. There may be new information. This Medication

More information

Accurate diagnosis of the generalized

Accurate diagnosis of the generalized The Generalized Rash: Part II. Diagnostic Approach JOHN W. ELY, MD, MSPH, and MARY SEABURY STONE, MD University of Iowa Carver College of Medicine, Iowa City, Iowa Although it is important to begin the

More information

CLINICAL MANIFESTATIONS OF PSORIATIC NAIL AT THE NATIONAL HOSPITAL OF DERMATOLOGY AND VENEREOLOGY (NHDV)

CLINICAL MANIFESTATIONS OF PSORIATIC NAIL AT THE NATIONAL HOSPITAL OF DERMATOLOGY AND VENEREOLOGY (NHDV) Southeast-Asian J. of Sciences: Vol. 2, No 1 (2013) pp. 101-107 CLINICAL MANIFESTATIONS OF PSORIATIC NAIL AT THE NATIONAL HOSPITAL OF DERMATOLOGY AND VENEREOLOGY (NHDV) Nguyen Huu Sau and Nguyen Minh Thu

More information

Nail Psoriasis. A positive approach. to psoriasis and. psoriatic arthritis

Nail Psoriasis. A positive approach. to psoriasis and. psoriatic arthritis Nail Psoriasis A positive approach to psoriasis and psoriatic arthritis What is psoriasis? Psoriasis (Ps) is a long-term (chronic) scaling disease of the skin, which affects 2% 3% of the UK population.

More information

Rheumatoid Arthritis: Symptoms, Causes, and Treatments of Rheumatoid Foot and Ankle

Rheumatoid Arthritis: Symptoms, Causes, and Treatments of Rheumatoid Foot and Ankle Rheumatoid arthritis is the most common form of inflammatory arthritis, affecting about two to three million Americans. Rheumatoid arthritis is a symmetric disease, meaning that it will usually involve

More information

Psoriasis and other papulosquamous dermatoses. Andrea Szegedi MD. DSci.

Psoriasis and other papulosquamous dermatoses. Andrea Szegedi MD. DSci. Psoriasis and other papulosquamous dermatoses Andrea Szegedi MD. DSci. Pityriasis rosea Pityriasis rosea irritata Pityriasis rubra pilaris Follicular erythematous papules Diffuse erythematous patches with

More information